{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:08:20Z","timestamp":1786993700801,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T00:00:00Z","timestamp":1653350400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.lanepe.2022.100429","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T05:52:40Z","timestamp":1657259560000},"page":"100429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Post-vaccination infection rates and modification of COVID-19 symptoms in vaccinated UK school-aged children and adolescents: A prospective longitudinal cohort study"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7773-8140","authenticated-orcid":false,"given":"Erika","family":"Molteni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liane S.","family":"Canas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Kl\u00e4ser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil S.","family":"Bhopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1345-3063","authenticated-orcid":false,"given":"Robert C.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Kerfoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole H.","family":"Sudre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan Capdevila","family":"Pujol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Polidori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prof Alexander","family":"Hammers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prof Tim D.","family":"Spector","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire J.","family":"Steves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prof Sebastien","family":"Ourselin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0577-1897","authenticated-orcid":false,"given":"Michael","family":"Absoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Modat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prof Emma L.","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanepe.2022.100429_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-4642(22)00022-0","article-title":"Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study","author":"Stephenson","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.lanepe.2022.100429_bib0002","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiab509","article-title":"Virologic features of SARS-CoV-2 infection in children","author":"Yonker","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lanepe.2022.100429_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-4642(21)00198-X","article-title":"Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2","volume":"5","author":"Molteni","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.lanepe.2022.100429_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.arcped.2021.07.004","article-title":"COVID-19 hospitalization rate in children across a private hospital network in the United States: COVID-19 hospitalization rate in children","volume":"28","author":"Kim","year":"2021","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.lanepe.2022.100429_bib0005","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm7046a4","article-title":"Incidence of SARS-CoV-2 Infection, Emergency Department Visits, and Hospitalizations Because of COVID-19 Among Persons Aged \u226512 Years, by COVID-19 Vaccination Status \u2014 Oregon and Washington, July 4\u2013September 25, 2021","volume":"70","author":"Naleway","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.lanepe.2022.100429_bib0006","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2107456","article-title":"Safety, immunogenicity, and efficacy of the BNT162b2 Covid-19 vaccine in adolescents","volume":"385","author":"Frenck","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanepe.2022.100429_bib0007","article-title":"Evaluation of the BNT162b2 Covid-19 vaccine in children 5 to 11 years of age","author":"Walter","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanepe.2022.100429_bib0008","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2110475","article-title":"Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting","volume":"385","author":"Barda","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanepe.2022.100429_bib0009","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2110737","article-title":"Myocarditis after Covid-19 vaccination in a large health care organization","volume":"385","author":"Witberg","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanepe.2022.100429_bib0010","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm7031e1","article-title":"COVID-19 Vaccine Safety in Adolescents Aged 12\u201317 Years \u2014 United States, December 14, 2020\u2013July 16, 2021","volume":"70","author":"Hause","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.lanepe.2022.100429_bib0011","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2117995","article-title":"Effectiveness of BNT162b2 vaccine against critical Covid-19 in adolescents","author":"Olson","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanepe.2022.100429_bib0012","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2114290","article-title":"Effectiveness of BNT162b2 vaccine against delta variant in adolescents","volume":"385","author":"Reis","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanepe.2022.100429_bib0013","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc0473","article-title":"Rapid implementation of mobile technology for real-time epidemiology of COVID-19","author":"Drew","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.lanepe.2022.100429_bib0014","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-020-0916-2","article-title":"Real-time tracking of self-reported symptoms to predict potential COVID-19","author":"Menni","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.lanepe.2022.100429_bib0015","doi-asserted-by":"crossref","DOI":"10.1038\/s41597-021-01071-x","article-title":"Accessible data curation and analytics for international-scale citizen science datasets","volume":"8","author":"Murray","year":"2021","journal-title":"Scient Data"},{"issue":"5","key":"10.1016\/j.lanepe.2022.100429_bib0016","first-page":"652","article-title":"Illness characteristics of COVID-19 in children infected with the SARS-CoV-2 Delta variant","volume":"9","author":"Molteni","year":"2022","journal-title":"Children (Basel)"},{"key":"10.1016\/j.lanepe.2022.100429_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(21)00224-3","article-title":"Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study","volume":"21","author":"Menni","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanepe.2022.100429_bib0018","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-020-10124-x","article-title":"Guillain\u2013Barr\u00e9 syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases","volume":"268","author":"Abu-Rumeileh","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.lanepe.2022.100429_bib0019","article-title":"Neutralizing antibody response to pseudotype severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) differs between mRNA-1273 and BNT162b2 coronavirus disease 2019 (COVID-19) vaccines and by history of SARS-CoV-2 infection","author":"Tyner","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanepe.2022.100429_bib0020","author":"Olson"},{"key":"10.1016\/j.lanepe.2022.100429_bib0021","doi-asserted-by":"crossref","unstructured":"Lutrick K, Rivers P, Yoo YM, et\u00a0al. Morbidity and Mortality Weekly Report. Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12\u201317 Years-Arizona, July\u2013December 2021. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/recommendations\/.","DOI":"10.15585\/mmwr.mm705152a2"},{"key":"10.1016\/j.lanepe.2022.100429_bib0022","doi-asserted-by":"crossref","DOI":"10.1111\/apa.16157","article-title":"Vaccinating children and adolescents against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), updated data from Israel","volume":"111","author":"Glikman","year":"2022","journal-title":"Acta Paediatr Int J Paediatr"},{"key":"10.1016\/j.lanepe.2022.100429_bib0023","doi-asserted-by":"crossref","DOI":"10.1111\/apa.15982","article-title":"Vaccinating children and adolescents against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)\u2014The Israeli experience","volume":"110","author":"Glikman","year":"2021","journal-title":"Acta Paediatr Int J Paediatr"},{"key":"10.1016\/j.lanepe.2022.100429_bib0024","doi-asserted-by":"crossref","DOI":"10.3201\/eid2711.211886","article-title":"Effectiveness of BNT162b2 vaccine in adolescents during outbreak of SARS-CoV-2 delta variant infection, Israel, 2021","volume":"27","author":"Glatman-Freedman","year":"2021","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.lanepe.2022.100429_bib0025","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1473-3099(22)00177-3","article-title":"Effectiveness of BNT162b2 against COVID-19 in adolescents","volume":"22","author":"Powell","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanepe.2022.100429_bib0026","article-title":"Attributes and predictors of long COVID","volume":"27","author":"Sudre","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.lanepe.2022.100429_bib0027","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.43955","article-title":"Frequency of adverse events in the placebo arms of COVID-19 vaccine trials: a systematic review and meta-analysis","author":"Haas","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.lanepe.2022.100429_bib0028","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2107058","article-title":"Prevention and attenuation of Covid-19 with the BNT162b2 and mRNA-1273 vaccines","volume":"385","author":"Thompson","year":"2021","journal-title":"N Engl J Med"}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776222001235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776222001235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T04:53:33Z","timestamp":1763009613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666776222001235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":28,"alternative-id":["S2666776222001235"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2022.100429","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.03.13.22272176","asserted-by":"object"}]},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-vaccination infection rates and modification of COVID-19 symptoms in vaccinated UK school-aged children and adolescents: A prospective longitudinal cohort study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2022.100429","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100429"}}